A combined structure-based pharmacophore modeling and 3D-QSAR study on a series of N-heterocyclic scaffolds to screen novel antagonists as human DHFR inhibitors
- 22 January 2021
- journal article
- research article
- Published by Springer Nature in Structural Chemistry
- Vol. 32 (4), 1-18
- https://doi.org/10.1007/s11224-020-01705-7
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Molecular Modeling Study of Dihydrofolate Reductase Inhibitors. Molecular Dynamics Simulations, Quantum Mechanical Calculations, and Experimental CorroborationJournal of Chemical Information and Modeling, 2013
- 3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin AnaloguesACS Medicinal Chemistry Letters, 2012
- Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetProceedings of the National Academy of Sciences, 2012
- 3D QSAR Pharmacophore Modeling, in Silico Screening, and Density Functional Theory (DFT) Approaches for Identification of Human Chymase InhibitorsInternational Journal of Molecular Sciences, 2011
- In Silico Exploration of Anti‐Inflammatory Activity of Natural CoumarinolignoidsChemical Biology & Drug Design, 2011
- Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributionsJournal of Cheminformatics, 2009
- Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancersCancer Chemotherapy and Pharmacology, 2009
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Performance of some variable selection methods when multicollinearity is presentChemometrics and Intelligent Laboratory Systems, 2005
- Validation of the general purpose QUANTA ®3.2/CHARMm® force fieldJournal of Computational Chemistry, 1992